Smoking Cessation and Nicotine de-addiction Products Market by product type, distribution channels and geographical regions. Key Vendors are Cipla Ltd., GlaxoSmithKline Plc., ITC Limited, Johnson & Johnson Services Inc., NJOY, Inc. and Novartis AG.

Precision Business Insights (PBI) in its report titled “Global smoking cessation and nicotine de-addiction products market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2017 and Forecast 2018-2025” assesses the market performance over eight years forecast period over 2018-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Market boosts and restraining factors
Across the globe, several governments are launching innovative awareness campaigns through digital, electronic and print media to alert the people regarding harmful effects of the smoking. All these government initiatives expected to drive the market for smoking cessation & nicotine de-addiction products over the forecast period. For instance, countries/regions like China, India and GCC countries brought laws that mandate the tobacco products manufacturers to place warning labels on the products and same laws prohibit the smoking in public areas, these are expected to create a market opportunity for the players.

Read more Insights at https://www.precisionbusinessinsights.com/market-reports/global-smoking-cessation-nicotine-de-addiction-products-market/

The growing prevalence of smoking and its hazardous effects on the cardiac and respiratory system is driving the smokers to adopt an alternative to smoking like nicotine-based products and E-cigarettes, this is expected to create a huge growth opportunity for market players over the forecast period. Moreover, consumers have choices to numerous innovative products in different formulations, which are helping buyers to choose the appropriate product for consumption, this in turn aiding the product adoption in the market. Moreover, regulatory approvals for Nicotine Replacement Therapies (NRT), non-nicotine based products and e-cigarettes are aiding the market revenue growth.

Avail sample report at https://bit.ly/2zi7vuN

North America holds the strongest position in the global market of smoking cessation and nicotine de-addiction products consumption

North America market holds the larger revenue share in global smoking cessation & nicotine de-addiction products market and projected to remain dominant over the forecast period owing to growing awareness and wider adoption choices in the region.
Asia-pacific Smoking cessation & nicotine de-addiction products market projected to grow at highest CAGR over the forecast period in comparison with other regions owing to large smoking population and growing interest of multinational players in the region for geographic expansion.

Some of the key players in the global Smoking Cessation & Nicotine De-addiction Products market include:
• Cipla Ltd. (India)
• GlaxoSmithKline plc. (UK)
• ITC Limited (India)
• Johnson & Johnson Services Inc. (U.S)
• NJOY, Inc. (U.S)
• Novartis AG (Switzerland)
• Pfizer, Inc. (U.S)
• Takeda Pharmaceuticals Co. Ltd. (Japan)
• VMR Products, LLC (U.S)

Technological advancements and strategic alliances are the key strategies adopted by market players

Players in smoking cessation & nicotine de-addiction products market are focusing on introducing newer and innovative therapies like Varenicline and Cytisine to garner larger market revenue share in global smoking cessation & nicotine de-addiction products market. Moreover, players entering into collaborations and partnership to increase the product market reach in various geographical areas.

Detailed segmentation
By Product Type
• Nicotine Based Products
 Nicotine Gums
 Nicotine Patches
 Nicotine Sprays
 Nicotine Inhalers
 Nicotine Lozenges
• Electronic Cigarette
• Non-nicotine Products
 Varenicline
 Bupropion
 Cytisine

By Distribution Channels
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Retail Stores

By Geography
• North America
• Europe,
• Asia-Pacific
• Latin America
• The Middle East & Africa

About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com

This release was published on openPR.